Recently, Jiangsu Huili Biotechnology Co., Ltd. (hereinafter referred to as "Huili Biotechnology") and Novozymes (China) Investment Co., Ltd. (hereinafter referred to as "Novozymes China") officially signed a strategic cooperation agreement to form a long-term strategic partnership in the fields of industrial biocatalysis, pharmaceutical intermediates and APIs. At the ceremony, Mr. Ye Yang, CEO of Huili Biologics, and Mr. Ye Xiaofeng, Vice President of Agriculture and Industry of Novozymes China, signed the contract on behalf of both parties.

 

 

In recent years, with the rapid development of synthetic biology technology, biological enzyme catalysis technology has set off a new wave of technological innovation in the field of industrial chemical production, according to McKinsey predicts that 70% of the products manufactured by chemical methods in the future can be produced by biological means. As a global leader in enzymes and microbial preparations, Novozymes currently accounts for 48% of the global enzyme market share. As an absolute industry leader, Novozymes continues to provide innovative biosolutions in more than 30 industries such as agriculture, renewable energy, light industrial washing, and biochemical industry. As one of the world's leading companies in bio-innovation, Novozymes hopes to further develop its presence in the field of industrial and medical biocatalytic enzyme preparations, and lead the industrial application of a new generation of biocatalytic enzymes. Huili Biotech is a synthetic biology company that develops innovative biocatalytic technology based on the core industrial enzyme element design platform, and has transformed products in the pharmaceutical field based on the first computing platform in China to realize the full-scenario design of enzymes, efficiently completed from laboratory development, industrialization to commercialization, and laid out more than 130 innovative products in multiple fields.

This cooperation will combine the advantages of Huili Biotech's world-leading enzyme computing design and development platform and Novozymes' years of resource accumulation in industrial enzyme application technology development and product market potential deep mining, and jointly carry out extensive and in-depth cooperation in biodegradable material new technologies, industrial chemical green biomanufacturing technology and other fields, accelerate the development process of AI-enabled new industrial enzyme catalysis technology from efficient design of core components to application expansion and form core technology products, and promote the development of biocatalysis industry technology. Promote sustainable development, realize green processing of enterprises, energy conservation and emission reduction.